Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
anti-aging drugs
Biotech
Alphabet's Calico weaves anti-aging deal with China's Mabwell
Alphabet’s Calico is inking a deal worth up to $571 million biobucks for rights to Mabwell's IL-11-targeting mAb for age-related diseases.
Gabrielle Masson
Jun 26, 2025 4:52pm
Advantage spins out anti-aging R&D to new biotech Klothea
Nov 25, 2024 11:56am
AgeX keeps defying time to survive multiyear cash crunch
Aug 15, 2023 7:00am
Optogenetic platform illuminates aging pathways in cells
Jul 19, 2023 12:58am
Time may be running out for anti-aging biotech AgeX
Aug 15, 2022 11:20am
Insilico's target discovery AI zeroes in on age-related diseases
Mar 29, 2022 3:55pm
